000 01740nam  2200349zi 4500
0019.885017
003CaOODSP
00520221107171024
006m     o  d f      
007cr cn|||||||||
008200225e202001  onc     ob   f000 0 eng d
020 |a9780660342405
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-296/2020E-PDF
1101 |aCanada. |bHealth Products and Food Branch, |eauthor.
24510|aHealth Products and Food Branch (HPFB) risk advisory opinion : |bpotential human health risks from chronic wasting disease / |cprepared by Health Products and Food Branch, Health Canada.
24617|aRisk advisory opinion : |bpotential human health risks from chronic wasting disease
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cJanuary, 2020.
264 4|c©2020
300 |a1 online resource (10 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Avis consultatif sur les risques de la Direction générale des produits de santé et des aliments (DGPSA) : risques pour la santé humaine liés à la maladie débilitante chronique.
500 |a"Pub.: 200205."
504 |aIncludes bibliographical references (pages 8-9).
650 0|aChronic wasting disease|xRisk assessment|zCanada.
650 0|aHealth risk assessment|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tAvis consultatif sur les risques de la Direction générale des produits de santé et des aliments (DGPSA) : |w(CaOODSP)9.885018
85640|qPDF|s960 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-296-2020-eng.pdf